INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
30/11/2024
Voltar para busca
Dado oficial do USPTO
MEDISON
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
46
Atualização mais recente
30/11/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 35
Data de depósito
16/11/2020
Data de registro
09/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/01/2024
Última transação
08/03/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
IL
Examinador
KHAN, ASMAT A
Unidade examinadora
M50
Localização atual
TMO LAW OFFICE 114
Descrição da marca
The mark consists of the stylized word MEDISON with the letters MEDIS and N in black and the letter "O" resembling a red ball partially covered by a white slightly curved band going bottom left to top right diagonally across it with the white band expanding in size from bottom to top.
Titulares e representantes
Titulares
MEDISON BIOTECH (1995) LTD.
Representantes
Susan O. Goldsmith McCarter & English LLP
Classificação técnica
Classes Nice
Classe 5Classe 35
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticalspharmaceutical preparations for the prevention and treatment of viral diseasesauto-immune and inflammatory diseasescardiovascular and pulmonary diseasescentral nervous system diseasesperipheral neurological system diseasespainallergiesanxietyinfectiondermatologic diseasesgastro-intestinal diseasesinfectious diseasesmetabolic diseasesoncologic diseasesophthalmic diseasesrespiratory diseasesdigital ulcerscerebrovascular diseases and medical preparations for the treatment of viral diseasesauto-immune and inflammatory diseasescardiovascular and pulmonary diseasescentral nervous system diseasesperipheral neurological system diseasespainallergiesanxietyinfectionsdermatologic diseasesgastro-intestinal diseasesinfectious diseasesmetabolic diseasesoncologic diseasesophthalmic diseasesrespiratory diseasesdigital ulcerscerebrovascular diseases; * none being generic or OTC pharmaceuticals or medical preparations; * vaccines; dietetic foods adapted for medical use
Classe 35
Marketingsales promotion for third partiesdistribution of samplesdistribution of advertising materials all in the fields of pharmaceutical preparationsmedical preparationsveterinary preparationsdietetic food and substancesmedical and veterinary apparatus and equipmentwholesale and retail store services featuring pharmaceutical preparationsmedical preparationsveterinary preparationsdietetic food and substancesmedical and veterinary apparatus and equipment * ; none of aforementioned services being in the field of generic pharmaceuticals or OTC product *
Publicações
Histórico de despachos e eventos da marca no USPTO.
46 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/11/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/04/2024
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
16/04/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/04/2024
FIMP
FINAL DISPOSITION PROCESSED
09/04/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/04/2024
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
11/03/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/01/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
01/01/2024
GPNX
NOTIFICATION PROCESSED BY IB
24/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/10/2023
PUBO
PUBLISHED FOR OPPOSITION
24/10/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/09/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
18/09/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
27/03/2023
GNFR
FINAL REFUSAL E-MAILED
27/03/2023
CNFR
FINAL REFUSAL WRITTEN
27/03/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
15/11/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/11/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/10/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19/10/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
24/06/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/06/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/11/2021
GNSL
LETTER OF SUSPENSION E-MAILED
03/11/2021
CNSL
SUSPENSION LETTER WRITTEN
03/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/10/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/10/2021
RFNT
REFUSAL PROCESSED BY IB
13/06/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/05/2021
RFRR
REFUSAL PROCESSED BY MPU
26/05/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/05/2021
CNRT
NON-FINAL ACTION WRITTEN
21/05/2021
MAFR
APPLICATION FILING RECEIPT MAILED
21/05/2021
DOCK
ASSIGNED TO EXAMINER
17/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/05/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MEDISON ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.